Chemo-boosting drug discovered for leukaemia
Drugs developed to treat heart and blood vessel problems could be used to treat leukaemia...
List view / Grid view
Drugs developed to treat heart and blood vessel problems could be used to treat leukaemia...
Scientists studying cellular enzyme complexes have unexpectedly found that inhibiting EZH2/1 suppressed viral infection in the herpes simplex virus infection...
The Medical Research Council has formed partnerships with UCB and AstraZeneca, the deals will help speed translation of discovery research into potential therapies...
Cancer research at the University of Warwick has received a boost thanks to the former Lord Mayor of Coventry Cllr Lindsley Harvard.
Dr Reda Lebcir from the University of Hertfordshire is part of an international team of researchers awarded a £2m grant from the ESRC (Economic and Social research Council).
Research reveals cathepsins as potential therapeutic targets in particulate-mediated inflammatory disease…
22 June 2017 | By Charles River Laboratories
40-65% of MS patients have cognitive impairment and touchscreen testing in animal models is a new method to test cognitive issues in MS animal models...
Elsevier has launched a new solution aimed at accelerating drug discovery through comprehensive prediction and assessment of drug-drug interactions (DDI).
Peer-reviewed paper on how touchscreen testing is a translational tool to assess cognitive function in a mouse model of Alzheimer’s disease...
Peer-reviewed publication on new strategies to target misfolded protein aggregates at various steps of protein production and processing...
Numab Therapeutics announced a collaboration and option agreement with Kaken Pharmaceutical for the identification of a multispecific antibody candidate for development in inflammatory disease.
In adult mammal hearts, cardiomyoctyes do not proliferate following damage, like that caused by myocardial infarction.
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.
The research, using tumour cells in the laboratory and in mice, will see if the Zika virus can destroy cancer cells.
The earliest phases of drug discovery used to be confined to research divisions of large pharmaceutical companies...